Tenax Therapeutics, Inc. (TENX) Earnings History
Net Loss30 years of earnings data (1996–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Tenax Therapeutics, Inc. (TENX) Earnings Overview
As of June 29, 2026, Tenax Therapeutics, Inc. (TENX) reported trailing twelve-month net income of -$58M, reflecting -16.5% year-over-year growth. The company earned $-1.28 per diluted share over the past four quarters.
Looking at the long-term picture, TENX's historical earnings data spans multiple years. The company achieved its highest annual net income of -$800,000 in fiscal 1998.
Tenax Therapeutics, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including ATHA (-$129M net income), NKTR (-$158M net income, -297.1% margin), ACAD ($376M net income, 36.5% margin), TENX has comparable earnings metrics. Compare TENX vs ATHA →
TENX Earnings vs Peers
Earnings metrics vs comparable public companies
TENX Historical Earnings Data (1996–2025)
30 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$53M | -198.8% | -$56M | $-1.34 | - | - |
| 2024 | -$18M | -128.3% | -$19M | $-1.15 | - | - |
| 2023 | -$8M | +30.2% | -$8M | $-31.04 | - | - |
| 2022 | -$11M | +66.0% | -$11M | $-600.80 | - | - |
| 2021 | -$32M | -229.6% | -$33M | $-2524.80 | - | - |
| 2020 | -$10M | -17.4% | -$10M | $-2125.38 | - | - |
| 2019 | -$8M | -23.2% | -$9M | $-26.60 | - | - |
| 2018 | -$7M | +22.9% | -$7M | $-7359.14 | - | - |
| 2017 | -$9M | +79.9% | -$9M | $-10022.32 | - | - |
| 2016 | -$44M | -211.9% | -$53M | $-624.82 | - | - |
| 2015 | -$14M | +0.0% | -$16M | $-200.61 | -28571.6% | -31729.6% |
| 2014 | -$14M | +27.9% | -$14M | $-16038.51 | -28571.6% | -27775.2% |
| 2013 | -$20M | -107.5% | -$17M | $-2141.41 | -6768.3% | -5844.3% |
| 2012 | -$9M | +40.1% | -$5M | $-4529.38 | -763.0% | -420.5% |
| 2011 | -$16M | -50.4% | -$8M | $-3580.64 | -3785.8% | -1980.6% |
| 2010 | -$10M | +0.6% | -$11M | $-290230.44 | -3241.3% | -3276.8% |
| 2009 | -$11M | -56.3% | -$10M | $-318405.33 | -22174.0% | -21528.5% |
| 2008 | -$7M | -101.8% | -$3M | $-3226.68 | - | - |
| 2007 | -$3M | +0.0% | -$2M | $-2893.89 | - | - |
| 2006 | -$3M | -24.6% | -$2M | $-3720.58 | - | - |
| 2005 | -$3M | -18.8% | -$2M | $-2552.82 | - | - |
| 2004 | -$2M | -1.0% | -$2M | $-2372.58 | - | - |
| 2003 | -$2M | +36.1% | -$2M | $-3013.99 | - | - |
| 2002 | -$3M | -108.6% | -$4M | $-4726.03 | - | - |
| 2001 | -$2M | +0.0% | -$2M | $-2378.72 | - | - |
| 2000 | -$2M | -83.5% | -$2M | $-209030.25 | - | - |
| 1999 | $-911,339 | -13.9% | $-911,597 | $-113917.37 | - | - |
| 1998 | $-800,000 | +58.1% | $-900,000 | $-3035.62 | - | - |
| 1997 | -$2M | +18.6% | -$2M | $-5366.22 | - | - |
| 1996 | -$2M | - | -$2M | $-6590.53 | - | - |
Download Data
Export TENX earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
30+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
TENX — Frequently Asked Questions
Quick answers to the most common questions about buying TENX stock.
What is TENX earnings per share (EPS)?
TENX trailing twelve-month (TTM) diluted EPS is $-1.28, reflecting -16.5% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 1996 to 2025 is available in the table on this page.
What is Tenax Therapeutics, Inc.'s net income?
Tenax Therapeutics, Inc. (TENX) trailing twelve-month net income is $-58M as of 2025. Earnings declined -16.5% year-over-year.
Is TENX profitable?
TENX is not currently profitable on a TTM basis, reporting a net loss of $-58M. Net margin is N/A. Investors should monitor for a return to profitability.
What is TENX's earnings growth rate?
TENX compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1996 to 2025.
What are TENX's profit margins?
Tenax Therapeutics, Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -55.6%.
Is TENX growing earnings?
TENX earnings are declining — EPS fell -16.5% year-over-year. TTM net income dropped to $-58M. This contrasts with the 5-year CAGR of N/A.
What was TENX's best earnings year?
Tenax Therapeutics, Inc.'s highest annual net income on record is $-800000.00, achieved in fiscal year 1998. Earnings history on this page spans 1996 to 2025 and includes all annual and quarterly figures.
What were TENX's earnings last quarter?
TENX's most recent reported quarter was Q1 2026. Net income was $-16M with diluted EPS of $-0.35. For a full breakdown of all quarters, see the quarterly earnings table on this page.